Abstract | OBJECTIVES: METHODS: To elucidate the involvement of Elf-1 in endometrial carcinogenesis, we analyzed serial frozen tissue sections from 31 patients with endometrial carcinoma and 20 patients with normal endometria for Elf-1 protein expression, using fluorescent immunohistochemistry. We analyzed the relationship between the percentages of Elf-1-stained cells and patient characteristics, including clinical stage, histological grade, presence of invasion to greater than one-half the myometrium, clinical outcome, and survival rate. RESULTS: Elf-1 was weakly detected in some normal endometria in the proliferative phase (0-18.9%) and other normal endometria in the secretory phase (0-28.5%). There was, however, abundant Elf-1 immunoreactivity in the nucleus of the endometrial carcinoma cells along with a little cytoplasmic staining. Scoring on the basis of the percentage of nuclear-positive cells indicated that nuclear Elf-1 expression was significantly associated with PCNA-labeling index, clinical stage, histological grade, the presence of invasion to greater than one-half the myometrium, and clinical outcome (P < 0.01, respectively). Survival data were available for all patients and demonstrated that Elf-1 expression was significantly associated with poor prognosis (P < 0.01). CONCLUSIONS:
|
Authors | Noriyuki Takai, Tami Miyazaki, Masakazu Nishida, Sujie Shang, Kaei Nasu, Isao Miyakawa |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 89
Issue 3
Pg. 408-13
(Jun 2003)
ISSN: 0090-8258 [Print] United States |
PMID | 12798703
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA-Binding Proteins
- Proliferating Cell Nuclear Antigen
- Transcription Factors
|
Topics |
- DNA-Binding Proteins
(biosynthesis, metabolism)
- Endometrial Neoplasms
(metabolism, pathology)
- Female
- Humans
- Neoplasm Invasiveness
- Neoplasm Staging
- Prognosis
- Proliferating Cell Nuclear Antigen
(metabolism)
- Transcription Factors
(biosynthesis, metabolism)
|